B
Binoj Nair
Researcher at Indian Institute of Technology Madras
Publications - 10
Citations - 794
Binoj Nair is an academic researcher from Indian Institute of Technology Madras. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 2, co-authored 2 publications receiving 691 citations.
Papers
More filters
Journal ArticleDOI
Coalescence of Nanoclusters and Formation of Submicron Crystallites Assisted by Lactobacillus Strains
Binoj Nair,Thalappil Pradeep +1 more
TL;DR: In this article, the growth of gold, silver, and gold-silver alloy crystals of submicron dimensions was observed by Lactobacillus strains, common in buttermilk, and the growth occurs by the coalescence of clusters, and tens of crystals were found within the bacterial contour.
Journal ArticleDOI
Alkyl Chain Dynamics in Monolayer-Protected Clusters (MPCs): A Quasielastic Neutron-Scattering Investigation
TL;DR: In this paper, the rotational motions of the alkyl chains in an isolated monolayer protected cluster (MPC), AuC18 (Cn = n carbon n-alkanethiolate), and a superlattice of AgC8 MPC have been investigated by quasielastic neutron scattering (QENS) technique in the temperature range of 300−400 K.
Journal ArticleDOI
Efficacy of Pirtobrutinib, a Highly Selective, Non-Covalent (Reversible) BTK Inhibitor in Relapsed / Refractory Waldenström Macroglobulinemia: Results from the Phase 1/2 BRUIN Study
M. Lia Palomba,Manesh R. Patel,Toby A. Eyre,Wojciech Jurczak,David John Lewis,Thomas Gastinne,Shuo Ma,Jonathon B. Cohen,Krish Patel,Jennifer R. Brown,Lydia Scarfò,Talha Munir,Ewa Lech-Marańda,Marc S. Hoffmann,Chaitra S. Ujjani,Bita Fakhri,Michael L. Wang,Koji Izutsu,Hirokazu Nagai,Constantine S. Tam,John F. Seymour,Joanna M. Rhodes,Julie M. Vose,Matthew McKinney,James N. Gerson,Minal A. Barve,Bryone J. Kuss,Youngil Koh,Wei Gao,Amy S. Ruppert,Richard A. Walgren,Donald E. Tsai,Binoj Nair,Katherine Jacobs Bao,Anthony R. Mato,Chan Yoon Cheah +35 more
TL;DR: Pirtobrutinib is well tolerated and has demonstrated promising efficacy in patients (pts) with poor-prognosis B-cell malignancies following prior therapy, including prior covalent BTKi as mentioned in this paper .
Journal ArticleDOI
Efficacy of Pirtobrutinib, a Highly Selective, Non-Covalent (Reversible) BTK Inhibitor in Richter Transformation: Results from the Phase 1/2 BRUIN Study
William G. Wierda,David John Lewis,Paolo Ghia,Nirav N. Shah,Catherine C. Coombs,Chan Yoon Cheah,E. Lamanna,Joanna Rhodes,Marc S. Hoffmann,Shuo Ma,Toby A. Eyre,Talha Munir,Manesh R. Patel,Alvaro J. Alencar,Constantine S. Tam,John F. Seymour,Wojciech Jurczak,Ewa Lech-Marańda,Lindsey E. Roeker,P. D. Thompson,Paolo Abada,Chunxiao Wang,Binoj Nair,Hui Liu,Donald E. Tsai,Anthony R. Mato +25 more
TL;DR: Pirtobrutinib is a well-tolerated highly selective, non-covalent (reversible) Bruton tyrosine kinase inhibitor (BTKi) with favorable oral pharmacology and promising efficacy in patients with poor prognosis following prior BTKi therapy as mentioned in this paper .
Journal ArticleDOI
Efficacy of Pirtobrutinib in Covalent BTK-Inhibitor Pre-Treated Relapsed / Refractory CLL/SLL: Additional Patients and Extended Follow-up from the Phase 1/2 BRUIN Study
Anthony R. Mato,Jennifer A. Woyach,Jennifer R. Brown,Paolo Ghia,Krish Patel,Toby A. Eyre,Talha Munir,Ewa Lech-Marańda,E. Lamanna,Constantine S. Tam,John F. Seymour,Nirav N. Shah,Catherine C. Coombs,Chaitra S. Ujjani,Manesh R. Patel,Bita Fakhri,Chan Yoon Cheah,Alvaro J. Alencar,Jonathon B. Cohen,James N. Gerson,Ian W. Flinn,Shuo Ma,Deepa Jagadeesh,Joanna Rhodes,Francisco J. Hernandez-Ilizaliturri,Pier Luigi Zinzani,Minna D. Balbas,Binoj Nair,Paolo Abada,Chunxiao Wang,Denise Wang,Donald E. Tsai,William G. Wierda,Wojciech Jurczak +33 more
TL;DR: Pirtobrutinib is well tolerated and has demonstrated promising efficacy in patients (pts) with poor-prognosis B-cell malignancies following prior therapy, including prior covalent BTKi as mentioned in this paper .